Startup Commentary”Wenzheng Chinese Medicine Challenges the Hong Kong Stock Exchange Again: “AI + Chinese Medicine” Fails to Conceal Loss Dilemma”
The innovative direction of “AI + TCM” is worthy of affirmation, but its commercialization requires a balance between technological ideals and market realities. If Wenzheng TCM wants to successfully list and achieve long – term development, it needs to make breakthroughs in key aspects such as technological reliability, profit model, and user trust.